Drontal cat duo 1 tablet
For the treatment of gastrointestinal roundworms and tapeworms in cats
Drontal Cat Film-coated Tablets.
2. DRONTAL CAT QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Constituents: mg per tablet
Pyrantel Embonate: 230.0
Relevant Constituents of the Excipients
Titanium Dioxide E171: 1.8 mg
For full list of excipients, see section 6.1
3. DRONTAL CAT PHARMACEUTICAL FORM
White to yellowish scored coated tablet. The tablet can be divided into equal halves.
4. DRONTAL CAT CLINICAL PARTICULARS
4.1 Target species
4.2 Indications for use, specifying the target species
For the treatment of gastrointestinal roundworms and tapeworms:
Toxocara cati, Toxascaris leonina, Dipylidium caninum, Taenia taeniaeformis.
Do not use simultaneously with piperazine compounds.
Not intended for use in kittens less than 6 weeks of age.
Do not use during pregnancy.
4.4 Special warnings for each target species
Fleas serve as intermediate hosts for one common type of tapeworm - Dipylidium caninum. Tapeworm infestation is certain to re-occur unless control of intermediate hosts such as fleas, mice etc is undertaken.
As a precautionary measure to prevent the establishment of Echinococcus multilocularis in the UK and Ireland, it is recommended that all dogs and cats entering the country be treated with praziquantel.
4.5 Special precautions for use
i. Special precautions for use in animals
ii. Special precautions to be taken by the person administering the medicinal product to animals
In the interests of good hygiene, persons administering the tablets directly to a cat, or by adding them to the cat’s food, should wash their hands afterwards.
4.6 Adverse reactions (frequency and seriousness)
4.7 Use during pregnancy and lactation
Not to be used during pregnancy but may be used during lactation.
4.8 Interaction with other medicinal products and other forms of interaction
Do not use simultaneously with piperazine compounds.
4.9 Amount(s) to be administered and administration route
The recommended dose rates are: 57.5 mg/kg pyrantel embonate and 5 mg/kg praziquantel. This is equivalent to 1 tablet per 4 kg bodyweight.
2 kg bodyweight ½ tablet
4 kg bodyweight 1 tablet
6 kg bodyweight 1 ½ tablets
Administration and Duration of Treatment
Single oral administration. The tablet should be given directly to the animal, but if necessary can be disguised in food.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
4.11 Withdrawal period(s)
5. DRONTAL CAT PHARMACOLOGICAL PROPERTIES
An anthelmintic active against gastrointestinal roundworms and tapeworms. The product contains two active ingredients:
Pyrantel embonate (pamoate) a tetrahydropyrimidine derivative and
Praziquantel, a partially hydrogenated pyrazino-isoquinoline derivative
ATC VetCode: QP52 AA51
Pharmacotherapeutic Group: Anthelmintics, Praziquantel combinations.
5.1 Pharmacodynamic properties
Pyrantel acts as a cholinergic agonist. Its mode of action is to stimulate nicotinic cholinergic receptors of the parasite, induce spastic paralysis and thereby allow expulsion from the gastrointestinal (GI) system by peristalsis.
Praziquantel is very rapidly absorbed into and distributed throughout the parasite. Both in vivo and in vitro studies have shown that praziquantel causes severe damage to the parasite integument, resulting in contraction and paralysis. There is an almost instantaneous tetanic contraction of the parasite musculature and a rapid vacuolisation of the syncytial tegument. This rapid contraction has been explained by changes in divalent cation fluxes, especially calcium.
In this fixed combination product pyrantel is active against the following ascarids: Toxocara cati and Toxascaris leonina. Praziquantel is effective against tapeworms in particular Dipylidium caninum and Taenia taeniaeformis.
The product has also been shown to be efficacious in the control of hookworms, Ancylostoma tubaeforme and A. braziliense and the tapeworm Joyeuxiella pasqualei, none of which occur naturally in the UK or Ireland but may occasionally be found in imported animals. Since it contains praziquantel, the product is effective against Echinococcus multilocularis, which does not occur in the UK or Ireland but is becoming more common in some European countries.
5.2 Pharmacokinetic properties
No data available.
6. DRONTAL CAT PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Titanium dioxide E171
Silica colloidial anhydrous
Shelf-life of the veterinary medicinal product as packaged for sale: 5 years.
6.4 Special precautions for storage
Do not store above 25°C.
Do not remove tablets from strip packaging until required for use.
Any part used tablets should be discarded.
6.5 Nature and composition of immediate packaging
Container material: Aluminium foil blister of polyethylene coated aluminium blister
Closure: Heat seal
Container colour: Silver or white coloured
Container sizes: Cartons containing 2, 24 or 96 tablets.
Not all pack sizes may be marketed.
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.